Metabolic Research Peptides · 10mg vial
PT-141
Buy 3+, save 10% · Kit of 10, save 25%
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II. Unlike PDE5 inhibitors, PT-141 acts centrally through melanocortin MC3R and MC4R receptors to modulate arousal and autonomic signalling pathways.
Research has investigated PT-141 for its effects on dopaminergic and serotonergic neural circuits involved in reward, motivation, and autonomic regulation. Its central mechanism of action distinguishes it from peripheral vasodilatory approaches studied in related fields.
Composition & Purity
PT-141 (Bremelanotide), Lyophilized powder
For research purposes only
Compound: PT-141 (Bremelanotide) — cyclic heptapeptide
CAS: 32780-32-6
Concentration: 10mg lyophilized powder
Purity: ≥99.7% (HPLC verified)
Storage: Refrigerate at 2–8°C. Protect from light. Reconstitute with bacteriostatic water prior to use.
COA: Available on request.
- Size
- 10mg vial
- Weight
- 10mg
Composition & Purity
PT-141 (Bremelanotide), Lyophilized powder
Suggested research dose: 0.5–2mg per administration. Consult published literature for specific protocol parameters. For research purposes only.
For research purposes only. Not for human or veterinary use.